Breast Cancer Clinical Trials

Showing 1241-1260 of 5,597 trials

A Study of ADRX-0706 in Select Advanced Solid Tumors

NCT06036121

The primary purpose of this study is to assess the safety, tolerability, and pharmacokinetics, and to identify the optimal dose of ADRX-0706 in patients with select advanced solid tumors.

Solid TumorsTriple Negative Breast Cancer (TNBC)Urothelial Cancer+1 more

Adcentrx Therapeutics144 participantsStarted Sep 2023

Los Angeles, California, United States • Los Angeles, California, United States • St. Petersburg, Florida, United States +18 more locations

Not Yet RecruitingPhase 2

Camrelizumab in Combination With Chemotherapy as Neoadjuvant Treatment in Patients With Early or Locally Advanced Triple-negative Breast Cancer

NCT07107217

To explore the application of Camrelizumab with chemotherapy as neoadjuvant treatment of early-stage TNBC. Phase II clinical study of Camrelizumab in neoadjuvant treatment of early-stage TNBC is proposed. The study aims to evaluate the efficacy and safety of Camrelizumab and to provide a new treatment option for neoadjuvant treatment of early-stage TNBC.

Breast Cancer

Blokhin's Russian Cancer Research Center40 participantsStarted Aug 2025

A Study of ADRX-0706 in Select Advanced Solid Tumors

Camrelizumab in Combination With Chemotherapy as Neoadjuvant Treatment in Patients With Early or Locally Advanced Triple-negative Breast Cancer

Related Searches

Clinico-biological Data Collection Study of Metastatic Breast Cancer

Phase II/III Study of SPH4336 Combined With Letrozole vs Placebo Combined With Letrozole in First-line Treatment of Breast Cancer

Efficacy and Safety of SPH4336 in Combination With Endocrine Therapy in Breast Cancer Patients With Brain Metastases.

Veliparib With or Without Carboplatin in Treating Patients With Stage III or IV Breast Cancer

Paclitaxel and Trastuzumab With or Without Lapatinib in Treating Patients With Stage II or Stage III Breast Cancer That Can Be Removed by Surgery

Conformal Partial Breast Irradiation With CyberKnife After Resection for Early Stage Breast Cancer

A Study on the Treatment of Early Small Breast Cancer With Ultrasound-guided Vacuum-assisted Excision Combined With Surgery

A Study of SNS-101 (Anti VISTA) Monotherapy and in Combination With Cemiplimab in Patients With Advanced Solid Tumors

Artificial Intelligence in Breast Cancer Screening Programs

Impact of 18F-FES PET on the Therapeutic Treatment of Patients With Metastatic Breast Cancer

Pecha Kucha Method Effects on Posttraumatic Growth and Psychological Resilience

Psychological Well-being in Patients With Breast Cancer

A Targeted Electronic Health Approach to Reduce Fear of Recurrence in Breast Cancer Survivors (FoRtitude)

CD40 Agonist, Flt3 Ligand, and Chemotherapy in HER2 Negative Breast Cancer

Exploration of Dalpiciclib Plus HDACi in HR+/HER2- Advanced Breast Cancer After Failure of CDK4/6 Inhibitor

Neoadjuvant Chemotherapy in Combination With Anlotinib and Benmelstobart for HR+/HER2- Breast Cancer (NEOTORCH-BREAST03)

SMART-ER: Symptom Monitoring With Patient-reported Outcomes

Determinants of Resistance to Endocrine Therapy and a Cyclin-dependent Kinases 4 and 6 (CDK4/6) Inhibitor for HR+ MBC